Table of Contents

• • General Information
• • Research and Publication Ethics
• • Submission of Manuscripts
• • Manuscript Preparation
• • Review Process
• • After Acceptance

General Information

Journal of Korean Gerontological Nursing is the official publication of the Korean Gerontological Nursing Society. This journal provides up -to -date knowledge for nursing educators, practitioners , and researchers of gerontological nursing field in Korea where seen as one of the fastest aging societies in the world. The journal emphasizes articles on the issues most important for addressing emerging clinical issues in acute and long-term care for older people. In addition, this journal aims to contribute to the exchange of information and the spread of knowledge at the national and international level on the future prospects and countermeasures for the care issues related to aging. The Journal accepts manuscripts reporting quantitative, qualitative, methodological, philosophical, and theoretical research, meta- analyses, integrative and systematic reviews, and instrument development, with the aims of improving the wellness and quality of care of the older adult population. Manuscripts in other categories will be considered by the Editorial Board.

The official title of the journal is 'Journal of Korean Gerontological Nursing' (pISSN 2384-1877, eISSN 2383-8086) and the abbreviated title is 'J Korean Gerontol Nurs'. The journal is published in February 28th, May 31th, August 31th, and November 30th. All submitted manuscripts are peer-reviewed by three reviewers. The text may be written in Korean or English. The abstracts, acknowledgements, tables, figures, and references should be written in English. The articles in this journal are indexed in National Research Foundation of Korea (NRF) database (Korea Citation Index). The circulation number is 500. Full text is available in the following URL address of the Journal: http://www.jkgn.org This Journal is indexed in SCOPUS, CINAHL, ScienceCentral, Google scholar and KCI. All rights reserved to the Korean Gerontological Nursing Society. No portion of the contents may be reproduced in any form without written permission of the publisher.

Research and Publication Ethics

For the policies on research and publication ethics that are not stated in these instructions, the Good Publication Practice Guidelines for Medical Journals (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=) or the Guidelines on Good Publication Practice (https://publicationethics.org/guidance/Guidelines) can be applied.

1. Conflict-of-interests statement

Authors are required to disclose commercial or similar relationships to products or companies mentioned in or related to the subject matter of the article being submitted. Sources of funding for the article should be acknowledged in a footnote on the title page. Affiliations of authors should include corporate appointments relating to or in connection with products or companies mentioned in the article, or otherwise bearing on the subject matter thereof. Other pertinent financial relationships, such as consultancies, stock ownership or other equity interests, or patent-licensing arrangements should be disclosed to the Editor-in-Chief in the cover letter at the time of submission. Such relationships may be disclosed in the Journal at the discretion of the Editor-in-Chief in footnotes appearing on the title page. Questions about this policy should be directed to the Editor-in-Chief. If there is no conflict of interest, this should also be explicitly stated as “The author(s) declared no conflicts of interest.”

2. Statement of human and animal rights

Clinical research should be done in accordance with the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). Clinical studies that do not meet the Declaration of Helsinki will not be considered for publication. Research participants’ rights to privacy must be protected, and personal identifiable information should not be disclosed unless absolutely necessary. Human subjects should not be identifiable, i.e., patients’ names, initials, hospital numbers, dates of birth, photographs, or other protected healthcare information should not be disclosed. If such personal information is needed as scientific data for publication, this should be explained to participants (or legal guardians) and written consent must be obtained. The possibility of online information sharing (not only printed publications) must also be explained. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained. For studies using literature review and meta-analysis, Institutional Review Board (IRB) approval is not required. For secondary data analysis studies, the editorial committee will decide whether IRB approval is needed.

3. Statement of informed consent

Copies of written informed consents and IRB approval for clinical research should be kept. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct.

4. Authorship

All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a paper assumes responsibility and accountability for the results. Artificial intelligence (AI) tools cannot be listed as an author of a paper.

5. Originality and duplicate publication

All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. Manuscripts are accepted for publication with the understanding that their contents, or their essential substance, have not been published elsewhere, except in abstract form or by the express consent of the Editors. Any part of the accepted manuscript should not be duplicated in any other scientific journal without the permission of the Editorial Board. The duplication will be checked through SimilarityCheck powered by iThenticate (https://www.crossref.org/services/similarity-check/) before review. If duplicate publication related to the papers of this journal is detected, the authors will be announced in the journal and their institutes will be informed, and there also will be penalties for the authors. Materials taken from other sources must be accompanied by written permissions for reproduction, obtained from the original publisher. Editors should follow the procedure set out in the Committee on Publication Ethics (COPE) flowcharts (https://publicationethics.org/resources/flowcharts-new/translations) that are designed to help editors follow COPE’s Code of Conduct and implement its advice when faced with cases of suspected misconduct.

6. Secondary publication

It is possible to republish manuscripts if the manuscripts satisfy the condition of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org).

7. Publication of master’s thesis or doctoral dissertation

When thesis or dissertation work is submitted for publication, the first author should be the thesis awarder and should declare that content is from thesis/dissertation.

Submission of Manuscripts

1. Anyone with an interest in gerontological nursing and related disciplines can become an author.
2. The manuscript should be prepared using MS word or HWP and submitted using online system (https://submit.jkgn.org/) or journal website (https://www.jkgn.org). In addition, the Copyright Transfer Agreement, the Self-review Form, and cover letter should be uploaded in the online submission system

3. Publication Type

• Original article: These include full papers reporting original research, on gerontological nursing.
• Review articles: Invited and submitted review papers are accepted. The body of review article should be a comprehensive, scholarly evidence-based review of the literature, accompanied by critical analysis and leading to reasonable conclusions.
• Editorials: These include comments by organizations or individuals on topics of current interest, by invitation only.
• Case report: Description of clinical cases should be unique and provide discussion that help advancement of nursing practice for better outcomes.

Manuscript Preparation

• 1. Manuscripts should be written in Korean or English. Manuscripts written in English should be submitted with a certificate of English editing.
• 2. Manuscripts should be typed in a 12-point font, double-spaced, in either Times New Roman or Courier, with a margin of at least one inch on all sides, and should be prepared according to the Citing Medicine: The NLM (National Library of Medicine) Style Guide for Authors, Editors, and Publishers, 2nd ed. If there are any discrepancies between the JKGN guidelines and the NLM Manual, the former has precedence.
• 3. The length of manuscript is limited to 6,000 words (excluding title page, abstract, references, tables, figures, and any supplemental digital content).
• 4. All manuscript pages are consecutively numbered throughout the paper (including references and tables). Original manuscripts should be no more than 20 double-spaced pages in length including tables, figures, and references. An abstract, notes, references, tables, and figures should be on separate pages. Illustrations submitted should be clean originals or digital files.

Composition of Manuscripts

• 1. Title page: The title page should include the name, title, affiliation, and ORCID numbers of all authors. This page should also include a mailing address, phone and fax numbers, acknowledgments, and authorships. Information identifying the authors should not appear elsewhere in the manuscript.
  • 1) Title - the title should be concise and informative, and limited to 100 characters.
  • 2) Authors - all author names (first name, middle initial(s),last name), with highest academic degree(s), professional titles, affiliations (institution and address), and emails
  • 3) Corresponding author - an individual who will handle correspondence should be provided with his/her affiliation, full postal address, email address, telephone number, and fax number.
  • 4) Running title - for all submissions except editorials, provide a short title limited to 45 characters.
  • 5) Funding sources - list grants or institutional or corporate support for the submission.
  • 6) Acknowledgements - state (1) contributions of others who did not merit authorship but participated in the research; and (2) Sponsor's role in the research process.
  • 7) Conflict of interests - state either that there are no conflicts of interest, or if conflicts do exist, explain them.
  • 8) Author contributions - Indicate authors' role in study concept and design, acquisition of subjects and/or data, data analysis and interpretation, and manuscript preparation.
  • 9) Data sharing statement - This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors (ICMJE)”
    (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement
  • 10) Word, reference, and table/figure count - for the abstract (if applicable), main text, references, and tables/figures.
• 2. Abstract: Abstracts are limited to 250 words, and should be typed double-spaces on a separate page. It should cover the main factual points, including statements of the purpose, methods, results, and conclusion. The abstract should be accompanied by a list of three to five keywords for indexing purposes; be very specific in your word choice. Use the MeSH keywords (http://www.nlm.nih.gov/mesh/meshhome.html).
• 3. Text
  　 Text should include the following sections: Introduction and Objectives, Methods, Results, Discussion, and Conclusion.
  
  • 1) Introduction and Objectives: Clearly state the need for this study and the main question or hypothesis of the study.
  • 2) Methods: Describe the study design, setting and samples, ethical considerations, measurements/instruments, data collection/procedure, and data analysis used.
    • Present an “Ethics statement” immediately after the heading “Methods” in a boxed format
    Example: Ethics statement: This study was approved by the Institutional Review Board (IRB) of XXXX University (IRB-201903-0002-01). Informed consent was obtained from the participants.
    • Description of participants
    Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
    •Software
    References to software programs used should be stated in the methods section. Example: Analyses were performed using SPSS, version 26 (IBM Corp. Armonk, NY, United States).
    • Authors are encouraged to describe the study according to the reporting guidelines relevant to their specific research design, such as those outlined by the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/National Library of Medicine (http://www.nlm.nih.gov/services/research_report_guide.html)
  • 3) Results: This section should be clear and concise.
  • 4) Discussion: This section should explore the significance of the reported findings.
  • 5) Conclusion: State the conclusions and recommendations for further study. Do not summarize the study results.
• 4. References
  
  • 1) In-text Citation
    References follow the NLM style. Reference should be numbered serially in the order of appearance in the text, with numbers in brackets ([ ]). When multiple references are cited together, use commas to indicate a series of non-inclusive numbers (e.g., [1], [2,3], [4-6], or [7-9,13]). If a reference is cited more than once, use the original reference number. If there are one or two authors, include the last name of each. If there are three or more authors, include only the last name of the first author followed by "et al." (e.g., Beck [3], Roberts & Gere [7], Vandervoort et al. [12]).
  • 2) Reference lists
    The number of references should be 30 or less for a regular article except for a manuscript on research (Systematic Review, Structural Equation Model, etc) which have no limit on references. Prepare the reference list as follows:
  •Journal articles
  
  • Up to 6 authors
    Elham H1, Hazrati M, Momennasab M, Sareh K. The effect of need-based spiritual/religious intervention on spiritual well-being and anxiety of elderly people. Holistic Nursing Practice. 2015;29(3):136-43. https://doi.org/10.1097/HNP.0000000000000083
    More than 6
    authors Bang KS, Kang JH, Jun MH, Kim HS, Son HM, Yu SJ, et al. Professional values in Korean undergraduate nursing students. Nurse Education Today. 2011;31(1):72-5. https://doi.org/10.1016/j.nedt.2010.03.01
  •Books
  
  • Peate I. The student's guide to becoming a nurse. 2nd ed. Chichester WS: John Wiley & Sons; 2012. 660 p
  •Technical and research report
  
  • Perio MA, Brueck SE, Mueller CA. Evaluation of 2009 pandemic influenza A (H1N1) virus exposure among internal medicine housestaff and fellows. Health Hazard Evaluation Report. Salt Lake City, Utah: University of Utah School of Medicine; 2010 October. Report No. HETA 2009-0206- 3117.
    
  •Electronic Media
  
  • Wilcox LS. 2010 life tables for Korea. Biological Procedures Online [Internet]. 2005 Nov [updated 2005 Sep 12; cited 2007 Jan 5]; 8(1):194-215. Available from:
    http://kostat.go.kr/portal/korea/kor_nw/3/
• 5. Tables / Figures
  
  • 1) Tables/Figures should be self-contained and complement, but not duplicate, information contained in the text. Tables/Figures should be numbered consecutively in Arabic numerals. Each table and figure should be placed on a separate page and in English. There should be no more than five tables and figures in total.
  • 2) The title of the table shall be placed on top of the table and the first letters of important words shall be capitalized (e.g., Table1. Overall Responses to Question Types). The title of the figure shall be placed below the figure with the first letter capitalized (e.g., Figure 1. Scatter plot for study variables between cancer survivors and their spouses.). When there are two or more figures for the same number, alphabets shall be placed after the Arabic number. (e.g., Figure 1-A, Figure 1-B).
  • 3) Always, define abbreviations in a legend at the bottom of a table/ figure, even if they have already been defined in the text. List abbreviations in alphabetical order.
  • 4) All units of measurements and concentrations should be designated. And when reporting decimal numbers, the significance level shall be rounded off to three decimal places; means, standard deviations, and a test statistic, to two decimal places; and percentages and mean age, to one decimal place (e.g., p=.005, 32.84± 3.47, 90.6%, 56.4 years).

Review Process

Similarity Test

Submitted papers are examined for plagiarism by similarity test. If the submitted article has a high similarity, the editorial board may refuse to publish or request revision.

Peer-review Process

All manuscripts are sent simultaneously to reviewers for double-blind peer review. This means that both the reviewer and the author are anonymous. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to two of the independent expert reviewers to assess the scientific quality of the paper. The editor is responsible for the final decision regarding acceptance or rejection of articles based on the reviewers’ comments. The editor's decision is final. Authors will be received notification of the publication decision, along with copies of the reviews and instruction for revision.

All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the selection of reviewers and decision process.

After Acceptance

Gallery Proofs: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Corrections should be kept to minimum. They must be checked carefully and returned within 7 days of receipt. Any fault found after the publication is the responsibility of the authors.

Fee for Page Charge: Publication processing fee of Korean Won 50,000, the page charge of Korean Won 60,000 per page should be paid by the corresponding author, if the manuscript is accepted for publication.

Complaints and Appeal: If there is any objection to the review results, corresponding authors(s) can appeal within 60 days after being notified. Editor-in Chief has the obligation to notify the results after one more review.

Reprints: The corresponding author of each article will receive free of charge for 10 offprints of his or her article and one complimentary copy of the issue in which the article appears at free of charge. Additional reprints may be ordered by using the special reprint order form.

Post-publication discussion: The postpublication discussion is available through letter to editor. All authors are obliged to provide retractions or corrections of mistakes. If any readers have a concern on any articles published, they can submit letter to editor on the articles. If there founds any errors or mistakes in the article, it can be corrected through errata, corrigenda, or retraction.

Archiving: It is accessible without barrier from National Library of Korea (https://nl.go.kr) in the event a journal in no longer published.